US20170071896A1
University of Texas System
1 - 11 . (canceled) 12 . A method of treating or preventing cancer comprising administering a pharmaceutical composition comprising 1-((3-(diethylamino)-2-hydroxypropyl)amino)-4-((oxiran-2-ylmethyl)amino)anthracene-9,10-dione to a subject diagnosed with, exhibiting symptoms of, or at risk of cancer.